Growth Metrics

Eton Pharmaceuticals (ETON) Depreciation & Amortization (CF) (2018 - 2025)

Eton Pharmaceuticals' Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $1.0 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 186.48% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a 252.88% increase, with the full-year FY2025 number at $4.0 million, up 252.88% from a year prior.
  • Depreciation & Amortization (CF) hit $1.0 million in Q4 2025 for Eton Pharmaceuticals, up from $1.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for ETON hit a ceiling of $1.2 million in Q2 2022 and a floor of $85000.0 in Q2 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $416350.0 across 5 years, with a median of $243000.0 in 2022.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 1277.65% in 2022 and later plummeted 85.31% in 2023.
  • Tracing ETON's Depreciation & Amortization (CF) over 5 years: stood at $137000.0 in 2021, then skyrocketed by 83.94% to $252000.0 in 2022, then rose by 28.97% to $325000.0 in 2023, then rose by 9.23% to $355000.0 in 2024, then skyrocketed by 186.48% to $1.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ETON at $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.